These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3021301)

  • 1. Adriamycin cardiotoxicity and calcium entry blockers: the need for caution in the combination.
    Rabkin SW; Godin DV
    Can J Cardiol; 1985; 1(5):IV-VII. PubMed ID: 3021301
    [No Abstract]   [Full Text] [Related]  

  • 2. [Myocardial cellular mechanism of action of calcium antagonists].
    Ferrari R; Boffa GM; Ciampalini G; Ceconi C
    Cardiologia; 1985 Feb; 30(2):77-89. PubMed ID: 3905004
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cardiotoxicity of daunomycin and adriamycin].
    Bossa R; Galatulas I; Mantovani E
    G Ital Chemioter; 1975; 22(1-2):27-30. PubMed ID: 1235348
    [No Abstract]   [Full Text] [Related]  

  • 4. Dependence of Ca outflow and depression of frog myocardium contraction on ryodipine concentration.
    Narusevicius E; Gendviliene V; Macianskiene R; Hmelj-Dunai G; Velena A; Duburs G
    Gen Physiol Biophys; 1988 Feb; 7(1):51-7. PubMed ID: 3396849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxorubicin cardiotoxicity may be caused by its metabolite, doxorubicinol.
    Olson RD; Mushlin PS; Brenner DE; Fleischer S; Cusack BJ; Chang BK; Boucek RJ
    Proc Natl Acad Sci U S A; 1988 May; 85(10):3585-9. PubMed ID: 2897122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium entry blockers and myocardial function.
    Nayler WG; Grinwald P
    Fed Proc; 1981 Dec; 40(14):2855-61. PubMed ID: 6273237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of caffeic acid phenethyl ester on doxorubicin-induced cardiotoxicity in rats.
    Fadillioglu E; Oztas E; Erdogan H; Yagmurca M; Sogut S; Ucar M; Irmak MK
    J Appl Toxicol; 2004; 24(1):47-52. PubMed ID: 14745846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of the antioxidant vitamin E to protect against adriamycin-induced cardiotoxicity in the rabbit.
    Breed JG; Zimmerman AN; Dormans JA; Pinedo HM
    Cancer Res; 1980 Jun; 40(6):2033-8. PubMed ID: 7371038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Formation of superoxide radicals in isolated cardiac mitochondria: effect of adriamycin].
    Sviriaeva IV; Ruuge EK; Shumaev KB
    Biofizika; 2007; 52(6):1054-9. PubMed ID: 18225657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prospective monitoring of adriamycin cardiotoxicity with systolic time intervals].
    Nakamura K; Miyake T; Kawamura T; Maekawa I
    Nihon Gan Chiryo Gakkai Shi; 1988 Aug; 23(8):1633-7. PubMed ID: 3193011
    [No Abstract]   [Full Text] [Related]  

  • 11. Selective inhibition of rat and human cardiac guanylate cyclase by doxorubicin (adriamycin): possible link to anthracycline cardiotoxicity.
    Levey GS; Levey BA; Ruiz E; Lehotay DC
    Trans Assoc Am Physicians; 1979; 92():303-8. PubMed ID: 44927
    [No Abstract]   [Full Text] [Related]  

  • 12. Reduction of doxorubicin-induced cardiotoxicity in mice by taurine.
    Hamaguchi T; Azuma J; Awata N; Ohta H; Takihara K; Harada H; Kishimoto S; Sperelakis N
    Res Commun Chem Pathol Pharmacol; 1988 Jan; 59(1):21-30. PubMed ID: 3353577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of mitochondrial calcium homeostasis following chronic doxorubicin administration.
    Solem LE; Henry TR; Wallace KB
    Toxicol Appl Pharmacol; 1994 Dec; 129(2):214-22. PubMed ID: 7527602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of Gingko biloba extract against doxorubicin-induced cardiotoxicity in mice.
    Naidu MU; Kumar KV; Mohan IK; Sundaram C; Singh S
    Indian J Exp Biol; 2002 Aug; 40(8):894-900. PubMed ID: 12597018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Calcium antagonists in the treatment of cardiovascular diseases (review of the literature)].
    Chekman IS; Nizhenkovskaia IV
    Vrach Delo; 1982 Sep; (9):47-52. PubMed ID: 6294997
    [No Abstract]   [Full Text] [Related]  

  • 16. L-type calcium channel blockers and EGTA enhance superoxide production in cardiac fibroblasts.
    Shivakumar K; Kumaran C
    J Mol Cell Cardiol; 2001 Feb; 33(2):373-7. PubMed ID: 11162140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Myocardial ultrastructure, energetics and function in chronic adriamycin-induced lesions].
    Kapel'ko VI; Popovich MI; Sharov VG; Kostin SI; Golikov MA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1988; 11(2):22-7. PubMed ID: 3233151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium entry blockers and cardiovacular failure.
    Vanhoutte PM
    Fed Proc; 1981 Dec; 40(14):2882-87. PubMed ID: 7308499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium channel blockers.
    Deedwania PC
    West J Med; 1982 Jul; 137(1):24-31. PubMed ID: 6291255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology and mechanisms of action of calcium-channel blockers.
    Katz AM
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):28S-37S. PubMed ID: 3540226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.